MP53: Prostate Cancer: Detection & Screening V

Poster Session Moderator(s)

• 

  Andre Luis Abreu, MD

  Assistant Professor of Clinical Urology and Radiology
  University Of Southern California
• RB

  Ryan Berglund, MD
• VF

  Vincenzo Ficarra

  University of Messina, Italy

Presentations:

• 7:00 AM – 8:15 AM

  MP53-01: Detection of clinically significant prostate cancer in mpMRI visible lesions: Size matters. Results from a large, two-institutional series.
  

  Poster Presenter: Armando Stabile, MD – San Raffaele Hospital Milan Italy
• 7:00 AM – 8:15 AM

  MP53-02: Comparison of Highest-grade Tumor Percentage in Core Samples from MRI-targeted Biopsy and Systematic Biopsy for Prostate Cancer Diagnosis
  

  Poster Presenter: Shu Wang, MD – University of Maryland School of Medicine
• 7:00 AM – 8:15 AM

  MP53-03: Effect of Targeted Cores on Risk Stratification in the Era of Image-guided Prostate Biopsy
  

  Poster Presenter: Samuel L. Washington, III, MD
• 7:00 AM – 8:15 AM

  MP53-04: Rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy core
  

  Poster Presenter: Benedikt Hoeh, MD
• 7:00 AM – 8:15 AM

  MP53-05: Clinically significant prostate cancer detection rate of Prostate Imaging Reporting and Data System score 4 in the peripheral zone
  

  Poster Presenter: Gang Song
• 7:00 AM – 8:15 AM

  MP53-06: MRI and MRI-targeted biopsy can detect cribriform cancer of the prostate
  

  Poster Presenter: Sho Uehara, MD – Dept. of Urology, Tokyo Medical and Dental Un
• 7:00 AM – 8:15 AM

  MP53-07: Histological Variants of Prostate Cancer are Under-reported in Prostate Biopsies Assessed Outside Tertiary Referral Centers. A Plea for Biopsy Review for Optimal Patient Management
  

  Poster Presenter: Simone Scuderi
• 7:00 AM – 8:15 AM

  MP53-08: Effect of Nearness to Cancer Centre on Prostate Cancer Outcomes and Patient&[prime]s Choice for The Type of Intervention
  

  Poster Presenter: Vahid Mehrnoush, MD,MSC – Northern Ontario School of Medicine
• 7:00 AM – 8:15 AM

  MP53-09: Machine Learning Models to perform Active surveillance on Prostate Cancer
  

  Poster Presenter: Derek Van Booven, BS – University of Miami
• 7:00 AM – 8:15 AM

  MP53-10: The role of SelectMDx in men undergoing primary prostate biopsy: a prospective multi-institutional study
  

  Poster Presenter: Martina Maggi, MD
• 7:00 AM – 8:15 AM

  MP53-11: Four Kallikrein Panel Testing Among Medicare Beneficiaries Undergoing Prostate Cancer Screening
  

  Poster Presenter: Michael Leapman, MD – Yale University Department of Urology
• 7:00 AM – 8:15 AM

  MP53-12: How do PSA-Based Markers Predict Clinically Significant Prostate Cancer (csPCa) on Prostate Biopsy Independent of Prostate Size
  

  Poster Presenter: Max Kuster, BA – Smith Institute For Urology
• 7:00 AM – 8:15 AM

  MP53-13: Transition of prostate cancer primary diagnostics: Takeover of MRI-guided targeted- versus systematic biopsy
  

  Poster Presenter: Fabian Falkenbach, MD
• 7:00 AM – 8:15 AM

  MP53-14: Feasibility of transperineal prostate biopsies under local anesthesia: a comparative study with the transrectal approach
  

  Poster Presenter: Camille Berquin
• 7:00 AM – 8:15 AM

  MP53-15: MRI-directed biopsy for primary detection of prostate cancer: MRI In-Bore vs MRI-transrectal ultrasound fusion-targeted techniques
  

  Poster Presenter: Francesco Del Giudice, MD
• 7:00 AM – 8:15 AM

  MP53-16: The trends of complication rates and the role of aztreonam as a prophylactic antibiotic after prostate biopsy
  

  Poster Presenter: Sung Jin Kim
• 7:00 AM – 8:15 AM

  MP53-17: Culture-directed antimicrobial prophylaxis in transrectal ultrasound-guided prostate biopsies: Contemporary 7-year experience
  

  Poster Presenter: Steven Sidelsky, MD
• 7:00 AM – 8:15 AM

  MP53-18: Continued PSA screening in men aged 60 years and older with very low serum prostate specific antigen in a large, integrated healthcare system
  

  Poster Presenter: James Kearns, MD – Northshore Medical Group
• 7:00 AM – 8:15 AM

  MP53-19: Prostate Specific Antigen Screening Utilization in Men with a Family History of Prostate Cancer and Extended Life Expectancy
  

  Poster Presenter: Taylor J. Malchow, BA
• 7:00 AM – 8:15 AM

  MP53-20: Added value of mpMRI in the stratification of patients with High-Risk Patients Prostate Cancer treated with radical prostatectomy: Implications for tailored multi-modal strategies.
  

  Poster Presenter: Giuseppe Cirulli